Trends and developments in liposome drug delivery systems.

By Tianshun Lian, R. Ho. Journal of Pharmacy and Science, 2001

872 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “The interested reader is directed to the following excellent reviews for further information regarding liposomes: Lian and Ho (2001), Constantinides et al. (2008), and Puri et al. (2009); and the following reviews are recommended for solid lipid nanoparticles: Müller et al. (2000), Mehnert and…”
The role of interparticle and external forces in nanoparticle assembly. (2008, methodology): “Both single-bilayer-membrane vesicles and multiwalled liposomes are found in cells, and have been produced and used as detergents and cosmetics, and are also currently being developed as target-specific drug-delivery vehicle”
Development of nanoparticles for antimicrobial drug delivery. (2010, background): “In 1995, Doxil (doxorubicin liposomes) became the first liposomal delivery system approved by the Food and Drug Administration (FDA) to treat AIDS associated Kaposi ’s sarcoma [11, 12].”
Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. (2013, background): “former case, significant efforts have been made to develop nanotechnology for well-designed targeted drug delivery system.(6) 8 Various types of nanocarriers such as liposomes, nanoparticles, and polymeric particles have been fabricated from various materials.”